Latest / Stock Movers / Cisco Soars, Ford Climbs, Regenxbio Sinks
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
- 0:08Speaker 2: Stock Movers Report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: I'm Carol Masser along with Tim Stentemick. Let's get to
- 0:19Speaker 3: some stocks on the move. And to be fair, we
- 0:22Speaker 3: do mention Cerebras because it is an IPO, the biggest
- 0:26Speaker 3: one of the year, and the stock is up seventy
- 0:29Speaker 3: four percent as we speak, but it was up as
- 0:31Speaker 3: much as one hundred and eight percent. It was an
- 0:33Speaker 3: oversubscribed IPO, and yeah, please, it's part of the AI
- 0:39Speaker 3: story and the semiconductor story. So interesting, interesting, interesting. So
- 0:43Speaker 3: ticker is CBRS. Let's go to another technique.
- 0:47Speaker 1: Yeah, it was one hundred and eighty five dollars IPO price. Okay,
- 0:49Speaker 1: that's what the number I was going for.
- 0:51Speaker 3: Okay, sorry, I couldn't read your mind. Let's bring it up.
- 0:57Speaker 3: It's been a long WEEKO.
- 0:59Speaker 1: You have to be with me for two more hours.
- 1:00Speaker 3: I know we've realized in the last twenty four hours.
- 1:03Speaker 3: We went to a breakfast together, we did a show together,
- 1:06Speaker 3: we went to kind of a dinner thing together.
- 1:08Speaker 1: And then I was like we gotta go.
- 1:11Speaker 3: He's like, I don't want to see you for a while.
- 1:14Speaker 3: I do want to see avalon Pronell. She's Blimberg News
- 1:17Speaker 3: Equities Report, and she joins us in studio with stocks.
- 1:19Speaker 4: Oh the move.
- 1:20Speaker 3: Let's talk about Cisco absolutely.
- 1:22Speaker 4: That's ticker CSCO currently up about thirteen percent to hit
- 1:26Speaker 4: a record intraday high. That's after reporting third quarter results
- 1:29Speaker 4: that very much came above expectations and also boosting its
- 1:32Speaker 4: full year outlook. Worth noting that it did also announce
- 1:36Speaker 4: job cuts as it continues to focus on sending those
- 1:39Speaker 4: resources towards AI. But Morgan Stanley said that their AI
- 1:43Speaker 4: preparation is really helping the company hit a growth rate
- 1:46Speaker 4: that they haven't achieved in fifteen years.
- 1:48Speaker 3: That's amazing, just soaring. And there was a period go
- 1:51Speaker 3: back a little bit where I think people were concerned
- 1:53Speaker 3: they were going to miss the whole AI craze, and
- 1:56Speaker 3: here they.
- 1:56Speaker 4: Are definitely proving some people wrong.
- 1:58Speaker 3: Yeah, exactly, exact, exactly where should we go next?
- 2:02Speaker 4: Forward? A different name that has also been kind of
- 2:05Speaker 4: popping on the AI trade that you wouldn't expect. That's
- 2:07Speaker 4: ticker f It's currently up about five point six percent
- 2:11Speaker 4: and on pace to notch it's best two day gains
- 2:13Speaker 4: since twenty twenty. That's partially because it's extending those gains
- 2:16Speaker 4: as investor enthusiasm for AI and more specifically, the automaker's
- 2:20Speaker 4: pivot toward energy storage builds. Part of that hype is
- 2:23Speaker 4: because of Morgan Stanley's great note yesterday, very bullish, saying
- 2:26Speaker 4: that the automaker's energy storage business could make a deal
- 2:30Speaker 4: with Hyperscalers soon, and we already know that's very much
- 2:33Speaker 4: involved with AI.
- 2:34Speaker 1: There are some analysts who are cautioning that the hype
- 2:36Speaker 1: around this energy storage a business could be short lived.
- 2:39Speaker 1: The stock is vulnerable to a quick reversal, but in
- 2:43Speaker 1: some have warned that the rally seems more like momentum
- 2:45Speaker 1: driven than a sober reevaluation of its prospects. That said,
- 2:50Speaker 1: this two day increase is pretty remarkable.
- 2:52Speaker 4: Exactly, and Celia is putting a lot of money towards
- 2:54Speaker 4: that as well.
- 2:55Speaker 3: Sounds like we could do a debate right to these
- 2:57Speaker 3: analysts right in terms of what they're thinking, which is
- 3:00Speaker 3: which is really interesting, but gosh, Ford, we're just a
- 3:04Speaker 3: different narrative that we're talking.
- 3:06Speaker 1: She wants to go biotech.
- 3:08Speaker 3: We have to how do you.
- 3:09Speaker 4: Say this company region x Bio, that's ticker rgn X.
- 3:12Speaker 4: It is sinking thirty seven percent most inter day on record.
- 3:16Speaker 4: Part of that is because they reported that two of
- 3:19Speaker 4: their patients who were taking this gene therapy had significant
- 3:22Speaker 4: complications or side effects. And while the goals were met
- 3:26Speaker 4: for this drug it's treating a very deadly muscular disease,
- 3:32Speaker 4: investors remain skittish. Serepta is also treating the same thing,
- 3:34Speaker 4: and they had a lot of issues last year, as
- 3:36Speaker 4: you guys remember, and so there's a lot of questions
- 3:39Speaker 4: of will just be able to make that accelerated approval
- 3:42Speaker 4: or not.
- 3:44Speaker 2: This stock mover's report from Bloomberg Radio. Check back with
- 3:48Speaker 2: us throughout the day for the latest roundup of companies
- 3:51Speaker 2: making news on Wall Street and for the latest market
- 3:54Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 3:58Speaker 2: Bloomberg dot com, and on Apple CarPlay and Android Auto
- 4:02Speaker 2: with the Bloomberg Business app.